CAMBRIDGE, Mass.--(BUSINESS WIRE)--Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) announced today that David S. Barlow, Chairman and Chief Executive Officer of Molecular Insight Pharmaceuticals, will present at the upcoming Thomson Reuters and BioCentury NewsMakers in the Biotech Industry Conference on Thursday, September 4, 2008. During his presentation, Mr. Barlow will provide an overview of the Company and its pipeline of molecular imaging radiopharmaceuticals and targeted molecular radiotherapeutic candidates. The presentation will take place at 9:30 a.m. Eastern Time in room 404/405 of the Millennium Broadway Hotel & Conference Center in New York, New York.
